Innova Captab Limited (NSE:INNOVACAP)

India flag India · Delayed Price · Currency is INR
680.75
+0.85 (0.13%)
Mar 9, 2026, 3:29 PM IST
-11.14%
Market Cap 38.96B
Revenue (ttm) 14.97B
Net Income (ttm) 1.32B
Shares Out 57.22M
EPS (ttm) 23.13
PE Ratio 29.43
Forward PE 22.08
Dividend 4.00 (0.59%)
Ex-Dividend Date Jan 30, 2026
Volume 20,950
Average Volume 27,315
Open 671.60
Previous Close 679.90
Day's Range 653.25 - 690.30
52-Week Range 622.00 - 1,020.70
Beta -0.50
RSI 49.96
Earnings Date May 21, 2026

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinoly... [Read more]

Sector Healthcare
Founded 2005
Employees 1,600
Stock Exchange National Stock Exchange of India
Ticker Symbol INNOVACAP
Full Company Profile

Financial Performance

In fiscal year 2025, Innova Captab's revenue was 12.44 billion, an increase of 15.02% compared to the previous year's 10.81 billion. Earnings were 1.28 billion, an increase of 35.95%.

Financial Statements

News

There is no news available yet.